![(S)-2-[(tert-Butoxycarbonyl)amino]-3-iodopropionic acid methyl ester](https://file.medchemexpress.com/product_pic/hy-z0424.gif "Click to View (S)-2-[(tert-Butoxycarbonyl)amino]-3-iodopropionic acid methyl ester Product Detail")
![(2S)-4-(Benzyloxy)-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid](https://file.medchemexpress.com/product_pic/hy-z0615.gif "Click to View (2S)-4-(Benzyloxy)-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid Product Detail")
![(2S)-4-(Benzyloxy)-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid (Standard)](https://file.medchemexpress.com/product_pic/hy-z0615r.gif "Click to View (2S)-4-(Benzyloxy)-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid (Standard) Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
11085 Results for "
parasite growth and maturation
" in MedChemExpress (MCE) Product Catalog:
Products (11085)
11085 Results for "parasite growth and maturation" in MCE Product Catalog:
Cat. No.: HY-Y1844
CAS No.: 104091-08-9
Target:
Research Areas:
Cat. No.: HY-Y1856
CAS No.: 19914-38-6
Target:
Research Areas:
Target:
Research Areas:
Cat. No.: HY-Z0291
CAS No.: 39825-33-7
Synonyms: Isopropyl L-alaninate; L-Alanine 2-propyl ester; L-Alanine isopropyl ester; O-Isopropyl-L-alanine
Target:
Research Areas:
Cat. No.: HY-Z0424
CAS No.: 170848-34-7
Synonyms: Methyl (2S)-2-(tert-butoxycarbonylamino)-3-iodopropanoate; Methyl (S)-2-[(tert-butoxycarbonyl)amino]-3-iodopropanoate
Target:
Research Areas:
Cat. No.: HY-Z0438
CAS No.: 13139-16-7
Target:
Research Areas:
Target:
Research Areas:
Research Areas:
Cat. No.: HY-Z0711
CAS No.: 37592-53-3
Target:
Research Areas:
Cat. No.: HY-Z0790
CAS No.: 261360-77-4
Target:
Research Areas:
Cat. No.: HY-P74216
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CTLA4; Celiac Disease 3; Prev. CELIAC3; Cytotoxic T Lymphocyte Associated Antigen 4 Short Spliced Form; Prev. IDDM12; Cytotoxic T-Lymphocyte-Associated Serine Esterase-4; CTLA-4; Cytotoxic T-Lymphocyte-Associated Protein 4; CD152; Cytotoxic T-Lymphocyte Antigen 4; Cytotoxic T-Lymphocyte Protein 4; Alternative Protein CTLA4; GSE; Celiac Disease; CD; CD152 Antigen; Cytotoxic T-Lymphocyte-Associated Antigen 4; ALPS5; Insulin-Dependent Diabetes Mellitus 12; GRD4; Gluten-Sensitive Enteropathy; Cytotoxic T-Lymphocyte Associated Protein 4; Ligand and Transmembrane Spliced Cytotoxic T Lymphocyte Associated Antigen 4
Species:
Rat
Source:
HEK293
Cat. No.: HY-P78841
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LILRB2; Monocyte/Macrophage Immunoglobulin-Like Receptor 10; Leukocyte Immunoglobulin Like Receptor B2; CD85 Antigen-Like Family Member D; MIR-10; Myeloid Inhibitory Receptor 10; LIR-2; Leucocyte Ig-Like Receptor B2; MIR10; ILT-4; ILT4; Leukocyte Immunoglobulin-Like Receptor 2; LIR2; Immunoglobulin-Like Transcript 4; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 2; Ig-Like Transcript 4; CD85d; CD85d Antigen; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 2
Species:
Human
Source:
HEK293
Cat. No.: HY-P78842
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRB2; Monocyte/Macrophage Immunoglobulin-Like Receptor 10; Leukocyte Immunoglobulin Like Receptor B2; CD85 Antigen-Like Family Member D; MIR-10; Myeloid Inhibitory Receptor 10; LIR-2; Leucocyte Ig-Like Receptor B2; MIR10; ILT-4; ILT4; Leukocyte Immunoglobulin-Like Receptor 2; LIR2; Immunoglobulin-Like Transcript 4; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 2; Ig-Like Transcript 4; CD85d; CD85d Antigen; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 2
Species:
Cynomolgus
Source:
HEK293
Cat. No.: HY-P700016AF
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TNFSF13; ZTNF2; TNF Superfamily Member 13; Tumor Necrosis Factor Ligand Superfamily Member 13 Epsilon; APRIL; Tumor Necrosis Factor-Related Death Ligand-1; Tumor Necrosis Factor Ligand Superfamily Member 13; Tumor Necrosis Factor Superfamily Member 13; A Proliferation-Inducing Ligand; Tumor Necrosis Factor-Like Protein ZTNF2; CD256; Tumor Necrosis Factor Ligand 7B; Tumor Necrosis Factor (Ligand) Superfamily, Member 13; TNF-Related Death Ligand 1; TNF- and APOL-Related Leukocyte Expressed Ligand 2; UNQ383/PRO715; TALL-2; CD256 Antigen; TRDL-1; TNLG7B; TALL2
Species:
Human
Source:
E. coli
Cat. No.: HY-P70733A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TNFSF13; ZTNF2; TNF Superfamily Member 13; Tumor Necrosis Factor Ligand Superfamily Member 13 Epsilon; APRIL; Tumor Necrosis Factor-Related Death Ligand-1; Tumor Necrosis Factor Ligand Superfamily Member 13; Tumor Necrosis Factor Superfamily Member 13; A Proliferation-Inducing Ligand; Tumor Necrosis Factor-Like Protein ZTNF2; CD256; Tumor Necrosis Factor Ligand 7B; Tumor Necrosis Factor (Ligand) Superfamily, Member 13; TNF-Related Death Ligand 1; TNF- and APOL-Related Leukocyte Expressed Ligand 2; UNQ383/PRO715; TALL-2; CD256 Antigen; TRDL-1; TNLG7B; TALL2
Species:
Human
Source:
HEK293
Cat. No.: HY-P704361
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: TNFSF13; ZTNF2; TNF Superfamily Member 13; Tumor Necrosis Factor Ligand Superfamily Member 13 Epsilon; APRIL; Tumor Necrosis Factor-Related Death Ligand-1; Tumor Necrosis Factor Ligand Superfamily Member 13; Tumor Necrosis Factor Superfamily Member 13; A Proliferation-Inducing Ligand; Tumor Necrosis Factor-Like Protein ZTNF2; CD256; Tumor Necrosis Factor Ligand 7B; Tumor Necrosis Factor (Ligand) Superfamily, Member 13; TNF-Related Death Ligand 1; TNF- and APOL-Related Leukocyte Expressed Ligand 2; UNQ383/PRO715; TALL-2; CD256 Antigen; TRDL-1; TNLG7B; TALL2
Species:
Human
Source:
HEK293
Cat. No.: HY-P86957
Synonyms: CXXC 3 antibody; CXXC-type zinc finger protein 3 antibody; CXXC3 antibody; MBD 1 antibody; Mbd1 antibody; MBD1_HUMAN antibody; MECP1 COMPLEX antibody; Methyl CpG binding domain protein 1 antibody; Methyl CpG binding domain protein 1 isoform PCM1 antibody; Methyl CpG binding protein MBD1 antibody; CXXC 3 antibody; CXXC-type zinc finger protein 3 antibody; CXXC3 antibody; MBD 1 antibody; Mbd1 antibody; MBD1_HUMAN antibody; MECP1 COMPLEX antibody; Methyl CpG binding domain protein 1 antibody; Methyl CpG binding domain protein 1 isoform PCM1 antibody; Methyl CpG binding protein MBD1 antibody; Methyl CpG binding protein splice variant 1 antibody; Methyl CpG binding protein splice variant 2 antibody; Methyl CpG binding protein splice variant 3 antibody; Methyl CpG binding protein splice variant 4 antibody; Methyl-CpG-binding domain protein 1 antibody; Methyl-CpG-binding protein MBD1 antibody; PCM 1 antibody; PCM1 antibody; Protein containing methyl-CpG-binding domain 1 antibody; Regulator of fibroblast growth factor 2 (FGF 2) transcription antibody; RFT antibody; The regulator of fibroblast growth factor 2(FGF 2) transcription antibody;
Cat. No.: HY-116028S1
CAS No.: 2750534-91-7
Synonyms: 15-Deoxy-Δ12,14-PGD2-d4
Cat. No.: HY-123996
CAS No.: 20041-64-9
Research Areas:
3-Ethoxy-5,6-dibromosalicylaldehyde is an IRE1/ERN1 inhibitor, with an IC50 of 0.12 μM, a Ki of 71-88 nM, and a Kd of 100 nM against the ribonuclease activity of hIRE1α, as well as an IC50 of 4.8 μM against yeast Ire1. It shows selectivity toward IRE1 ribonuclease. 3-Ethoxy-5,6-dibromosalicylaldehyde blocks the IRE1/ERN1-mediated unfolded protein response (UPR) signaling pathway, including XBP-1 mRNA splicing, induction of XBP1 target genes, and activation of MAPK8/9/10, but does not alter the phosphorylation level of IRE1α or the PERK/ATF6 pathway. 3-Ethoxy-5,6-dibromosalicylaldehyde inhibits chikungunya virus replication, induces growth arrest, apoptosis and clonogenic inhibition in pancreatic cancer cells, reduces FB1 (Fumonisin B1) (HY-N6719)-induced autophagy and cell death, regulates PGG-induced senescence and apoptosis, and alleviates Sorafenib (HY-10201)-induced vacuolization and damage in hepatic stellate cells. 3-Ethoxy-5,6-dibromosalicylaldehyde can be used in research related to chikungunya virus infection, pancreatic cancer, FB1-induced nephrotoxicity, liver cancer, breast cancer, lung cancer and liver fibrosis .
Cat. No.: HY-175340
CAS No.: 1361107-81-4
Target:
Research Areas:
Kv7.2/Kv7.3 activator-3 (GRT-X) is an orally active Kv7.2/Kv7.3 and TSPO activator. Kv7.2/Kv7.3 activator-3 activates Kv7.2/Kv7.3, Kv7.4, and Kv7.5 with EC50 values of 0.37, 2.06, and 0.75 μM, respectively, and binds to TSPO with Ki values of 0.07 μM (rat membrane) and 4.60 μM (human U-118 MG cells). Kv7.2/Kv7.3 activator-3 prevents motor neuron degeneration in mice and humans conditioned by ALS/FTD astrocytes. Kv7.2/Kv7.3 activator-3 stimulates dorsal root ganglion axonal growth through TSPO and Kv7.2/3 activation. Kv7.2/Kv7.3 activator-3 has anti-epileptic effects in epileptic seizure models. Kv7.2/Kv7.3 activator-3 reduces pain hypersensitivity in patients with diabetic neuropathy, promotes neuronal survival and regeneration after cervical neuropathy in rats, and accelerates the recovery of normal function of sensory and motor neurons .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
